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Characteristics of 681 Low Vision Patients in Korea
The purpose of our study was to evaluate the characteristics and the changes of low vision 
patients over ten years in Korea, and to establish useful data for planning low vision 
services, active care and rehabilitation. We conducted a retrospective study of 681 low 
vision patients who visited two low vision clinics in Seoul from 1995 to 2008. Age and sex 
distribution, cause of low vision, type of prescribed low vision aids, and changes of the 
characteristics were reviewed. In result, male were more than female. The age group 
between 11 and 20-yr-old (18.1%) was the largest age group. Optic atrophy (28.3%) was 
main causes of low vision. However, elderly low vision patients is increasing and macular 
degeneration is becoming a leading cause of low vision (P<0.05). One thousand five low 
vision aids (LVAs) were prescribed for 681 patients (1.46±0.62 aids for each patient). Near 
LVAs were prescribed more than distance LVAs. In most patients, the use of LVAs improved 
both near and distance visual function. This study is the first survey of a large number of 
low vision patients over a ten year period in Korea. On the base of this study, the planning 
of low vision services and more active rehabilitation for low vision patients, especially 
elderly patients, need in Korea.
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INTRODUCTION 
According to a World Health Organization (WHO) consultation 
report, person with low vision is someone who has: an impair-
ment of visual function, even after treatment or refractive cor-
rection; a visual acuity of less than 6/18 (20/60) to perception of 
light or a visual field of less than 10° in the better eye, but who 
uses, or is potentially able to use, vision for the planning and/or 
execution of a task (1). Low vision is one of the priorities in the 
global initiative, VISION 2020—The Right to Sight, along with 
cataract, trachoma, onchocerciasis, childhood blindness, and 
refractive error (2). In Korea, there are 216,881 patients on record 
as having visual impairment which includes low vision and bin-
ocular or monocular blindness (3). However, there has not been 
any clinical data collected from the large number of low vision 
patients in Korea. It is important to collect and analyze data from 
low vision patients in order to offer low vision care. Therefore, 
we investigated characteristics of low vision patients such as age 
and sex distribution, cause of low vision, type of prescribed low 
vision aids, and changes of the characteristics over a ten year 
period in Korea. We expect these data can be useful for planning 
low vision services, active care and rehabilitation.
MATERIALS AND METHODS
We reviewed the medical records of 681 patients who visited the 
low vision clinic at either the National Medical Center or Chung-
Ang University Hospital in Seoul, Korea, more than twice be-
tween May 1995 and December 2008. 
  At the initial visit, a detailed past medical history was obtained 
for each patient, and ocular examinations were performed. Oc-
ular examinations included: measurement of visual acuity (VA); 
assessment of pupillary reaction; measurement of intraocular 
pressure (IOP) using Goldmann applanation tonometry; slit-
lamp biomicroscopic examination; fundus examination (with 
an indirect ophthalmoscope using a 20-diopter lens and with a 
slit lamp using a 90-diopter lens) after dilatation, unless contra-
indicated because of the risk of angle closure; color vision test; 
contrast sensitivity test; and visual field screening using the Hum-
phrey Automated Field Analyzer (Swedish Interactive Thresh-
olding Algorithm Standard 24-2). In addition, a visual evoked 
potential test and electroretinography were carried out in accor-
dance with the cause of low vision. Distance and near VA were 
first measured for each eye without refractive correction using 
the Dr. Han’s standard test chart at a distance of 5 m and a Light-
house near chart at a distance of 40 cm under illumination from 
a 600 to 700 lux light source. The examination was repeated with 
full correction of refractive errors to obtain the distance and near 
best-corrected visual acuity (BCVA). If a patient’s distance BCVA 
was under 20/200, the VA was measured using the Finebloom 
chart or low vision letter chart. On a second visit one to two weeks 
from the date of the initial visit, each patient was made to prac-
tice with more than two low vision aids (LVAs) for distance and 
near vision, in accordance with his or her test results and the Kim JH, et al.  •  Low Vision Patients in Korea
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daily activity that he or she wanted to achieve in the future. On 
the third visit, we prescribed the LVAs that were the easiest and 
most comfortable for the patient to use. Each patient revisited 
the clinic after one month, whereupon we determined if the 
LVA met his or her needs. 
  In order to investigate changes in the characteristics of low 
vision patients over time, we compared the data of 350 patients 
including age, the cause of low vision, and the prescription of 
LVAs from May 1995 to April 1999 with those of 331 patients from 
May 1999 to December 2008.
  Statistical Package for the Social Sciences (SPSS) software 
program, version 16.0 (SPSS Inc., Chicago, IL, USA.), and results 
were considered statistically significant when the P value was 
<0.05.
  Our study was approved by the Institutional Review Board of 
Chung-Ang University College of Medicine (IRB No. C2009091 
[278]).
 
RESULTS
There were 440 (64.6%) men and 241 (35.4%) women, with an 
age range of 5 to 90 yr (mean age of 33.8 yr) included in this 
study. The largest age group was those between 10 and 19 yr of 
age (20.4%), followed by that between 20 and 29 yr of age (16.4 
%), and below 10 years of age (16%) (Table 1). When comparing 
the data from May 1995 to April 1999 with that from May 1999 
to December 2008, the proportion of low vision patients under 
20-yr-old decreased (43.1% to 20.9%) (Pearson’s chi-square test, 
P<0.05). And the proportion of low vision patients over 60-yr-
old increased (12.6% to 26.3%) significantly (Pearson’s chi-square 
test, P<0.05). With regard to sex distribution, the proportion of 
women increased (31.7% to 39.3%) significantly. (Pearson’s chi-
square test, P<0.05)
  The most common cause of low vision was optic nerve atro-
phy (28.3%), followed by macular degeneration (20.8%). When 
comparing the data from 1995 to 1999 with those from 1999 to 
2008, the proportion of optic atrophy, congenital cataract, and 
amblyopia decreased more than 1%, while the proportion of 
macular degeneration, diabetic retinopathy, and other diseases 
increased (Table 2).
  One thousand five LVAs were prescribed for 681 patients (1.46 
±0.62 aids for each patient) (Table 3). Among these, LVAs for 
near vision (39.2%, 394 aids) were prescribed more than LVAs 
for distance vision (60.8%, 611 aids). When comparing the data 
from 1995 to 1999 with those from 1999 to December 2008, the 
number of prescribed LVAs for each patient showed a signifi-
cant increase (1.32±0.53 aids per patient to 1.64±0.77 aids per 
patient) (paired t-test, P<0.05). The prescribed proportion of 
telescope and spectacle-type LVAs decreased and that of mag-
nifier LVAs increased. The prescription of prism lenses and elec-
tric LVAs including EYE FINE® (Nittoh & Kogaku, Nagano, Japan) 
and PocketViewer® (HumanWare, Christ Church, New Zealand) 
began in 2000.
  Before the use of LVAs, distance BCVA was typically worse than 
20/100 (91.2%). There were 245 (36.0%) patients whose distance 
BCVA was between 20/200 and 20/100 (the largest group). After 
the use of LVAs, distance BCVA was typically better than 20/63 
(88.2%), and there were 328 (48.2%) patients whose distance 
BCVA was better than 20/32 (the most prevalent group) (Table 4).
  Near BCVA was also typically worse than 20/100 (88.0%), and 
Table 1. Age and sex distribution of 681 low vision patients 
Age (yr)
No. of patients (%) in 1995-2008 No. of patients (%) in 1995-1999 No. of patients (%) in 1999-2008
Male Female Total Male Female Total Male Female Total
<10 51 46   97 (14.2) 39 29   68 (19.4) 12 17 29 (8.8)
10-19 76 47 123 (18.1) 54 29   83 (23.7) 22 18   40 (12.1)
20-29 78 21   99 (14.5) 36   8   44 (12.6) 42 13   55 (16.6)
30-39 55 27   82 (12.0) 41 12   53 (15.1) 14 15 29 (8.8)
40-49 45 23   68 (10.0) 20   7 27 (7.7) 25 16   41 (12.4)
50-59 48 33   81 (11.9) 19 12 31 (8.9) 29 21   50 (15.1)
60-69 49 22   71 (10.4) 16   5 21 (6.0) 33 17   50 (15.1)
70-79 26 17 43 (6.3) 10   6 16 (4.6) 16 11 27 (8.2)
80< 12   5 17 (2.5)   4   3   7 (2.0)   8   2 10 (3.0)
Total 440 (64.6%) 241 (35.4%) 681 239 (68.3%) 111 (31.7%) 350 201 (60.7%) 130 (39.3%) 331
Table 2. Causes of low vision in 681 low vision patients in Korea 
Cause of low vision
No. of patients (%) 
in 1995-2008
No. of patients (%) 
in 1995-1999
No. of patients (%) 
in 1999-2008
Optic atrophy 192 (28.2) 121 (34.6)   71 (21.5)
Macular degeneration 141 (20.7)   58 (16.6)   83 (25.1)
Retinitis pigmentosa 65 (9.5) 32 (9.1)   33 (10.0)
Diabetic retinopathy 50 (7.3) 22 (6.3) 28 (8.5)
Congenital cataract 37 (5.4) 27 (7.7) 10 (3.0)
Amblyopia 31 (4.6) 18 (5.1) 13 (3.9)
Corneal opacity 28 (4.1) 15 (4.3) 13 (3.9)
Nystagmus 24 (3.5) 11 (3.1) 13 (3.9)
ROP 21 (3.1) 11 (3.1) 10 (3.0)
Albinism 22 (3.2) 12 (3.4) 10 (3.0)
Retinal detachment 19 (2.8)   8 (2.3) 11 (3.3)
Aniridia 14 (2.1)   8 (2.3)   6 (1.8)
Other 37 (5.4)   7 (2.0) 30 (9.1)
Total 681 350 331
ROP, Retinopathy of prematurity.Kim JH, et al.  •  Low Vision Patients in Korea
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there were 267 (39.2%) patients whose near BCVA was between 
20/200 and 20/100 (the largest group) prior to the use of LVAs. 
After the use of LVAs, near BCVA was typically better than 20/63 
(82.1%), and there were 376 (55.2%) patients whose near BCVA 
was better than 20/32 (the most prevalent group) (Table 5).
 
DISCUSSION 
Low vision is a very important public health problem. Previous 
worldwide population-based studies have demonstrated con-
sistently that the prevalence of low vision has been increasing 
significantly and that most low vision patients are elderly (4). In 
contrast, young patients accounted for a large proportion of the 
low vision patients (46.8% under 30-yr-old) in this study. This is 
possibly because low vision clinics and care have been largely 
unknown to the elderly and there are many young low vision 
patients detected from vision tests in schools. However, when 
comparing the data from May 1995 to April 1999 with those from 
May 1999 to December 2008, the proportion of low vision young 
patients, especially those under 20-yr-old, showed a significant 
decrease and the proportion of low vision elderly patients show-
ed an obvious increase. An increasingly older population, in-
creasing attention on the health, increasing social behaviors, 
and increasing concern and publicity regarding low vision are 
possible reasons for this changed trend. The increased number 
of low vision clinics (there are presently 11 low vision clinics in 
Korea) likely explains the decrease in the number of low vision 
patients from 1999 to 2008 compared to that of 1995 to 1999 in 
this study.  
  Concerning the causes of low vision, in this study, the most 
common cause was optic nerve atrophy, which is consistent with 
other low vision reports in Korea (5). However, since 1999, the 
most common cause of low vision has been macular degenera-
tion including age-related macular degeneration and diabetic 
retinopathy which showed increased proportions. This may be 
related to the increase in elderly low vision patients. As congen-
ital cataract, amblyopia, and corneal opacity are preventable 
with early treatment, the proportion of these low vision causes 
has decreased and may decrease further. The reason why other 
causes of low vision have increased is likely because unexplained 
Table 3. The type and number of prescribed low vision aids (LVAs) in 681 low vision patients 
Low vision aids (LVAs) No. of LVAs (%) in 1995-2008 No. of LVAs (%) in 1995-1999 No. of LVAs (%) in 1999-2008
1. Distance-Telescope    394 (39.2) 191 (41.4) 203 (37.3)
   Galilean type telescope
   Keplerian type telescope
   69 (6.9)
   325 (32.3)
27 (5.9)
164 (35.6)
42 (7.7)
161 (29.6)
2. Near    611 (60.8) 270 (58.6) 341 (62.7)
   1) Magnifier    300 (29.9) 129 (28.0) 171 (31.4)
       Hand-held magnifier
       Stand magnifier
   228 (22.7)
   72 (7.2)
  92 (20.0)
37 (8.0)
136 (25.0)
35 (6.4)
   2) Electric LVA*    35 (3.5) 0 35 (6.4)
   3) Spectacle-type LVA 255 (27.8) 141 (30.6) 135 (24.8)
       Aspherical doublet lens
       Telemicroscopic with cap or clip-on
       Loupe
       Half-eye
       Prism lens
       Bifocal lens
       High power reading glass
   76 (7.6)
   69 (6.9)
   33 (3.3)
   32 (3.2)
   30 (3.0)
   18 (1.9)
   17 (1.7)
  49 (10.6)
43 (9.3)
18 (3.9)
15 (3.3)
0 
  8 (1.7)
  8 (1.7)
27 (4.8)
26 (4.8)
15 (2.8)
17 (3.1)
30 (5.5)
  8 (2.0)
  9 (1.7)
Total 1005 461 544
No. of LVAs for each patient 1.46±0.62 1.32±0.53
† 1.64±0.77
†
*Electric low vision aid includes eye fine
® and pocket viewer
®; 
†significance: P<0.05, paired t-test. 
Table 4. Distance best corrected visual acuity (BCVA) in patients with and without low 
vision aids (LVAs)
Distance BCVA
No. of patients 
without LVAs (%) 
No. of patients
with LVAs (%)
LP (+) <VA <20/400 227 (33.3)   6 (0.9)
20/400 ≤VA <20/200 149 (21.9)   7 (1.0)
20/200 ≤VA <20/100 245 (36.0) 22 (3.2)
20/100 ≤VA <20/63 60 (8.8) 47 (6.9)
20/63 ≤VA <20/40 0 146 (21.4)
20/40 ≤VA <20/32 0 125 (18.4)
20/32 ≤VA 0 328 (48.2)
Total 681 681
VA, visual acuity.
Table 5. Near best corrected visual acuity (BCVA) in patients with and without low 
vision aids (LVAs)
Near BCVA
No. of patients 
without LVAs (%)
No. of patients 
with LVAs (%)
LP (+) <VA <20/400 134 (19.7) 0
20/400 ≤VA <20/200 198 (29.1) 0
20/200 ≤VA <20/100 267 (39.2) 28 (4.1)
20/100 ≤VA <20/63   82 (12.0)   94 (13.8)
20/63 ≤VA <20/40 0 63 (9.3)
20/40 ≤VA <20/32 0 120 (17.6)
20/32 ≤VA 0 376 (55.2)
Total 681 681
VA, visual acuity.Kim JH, et al.  •  Low Vision Patients in Korea
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optic atrophy or retinal degeneration have been more readily 
identified with advanced diagnostic methods. 
  Most low vision aids are used for near vision, and it is impor-
tant to consider a patient’s working distance and purposes when 
prescribing LVAs (6-8). So near LVAs like magnifiers and spec-
tacle-type aids were more prescribed than distance LVAs like 
telescopes. This suggests that near vision activities, such as read-
ing, have been more important for low vision patients. Recently, 
EYE FINE® (Nitto & Kogaku), which has an advantage of usabil-
ity in both near and distance viewing by auto-focusing according 
to working distance and PocketViewer® (HumanWare), a com-
pact portable hand-held electric magnifier, have been developed 
and put to use. These electric LVAs have been used by low vision 
patients since 2000. Prism lenses have been also used recently 
for eccentric viewing, visual field shift, or field expansion. 
  Although the detailed data were not shown in this paper, there 
were more prescribed LVAs in each cause of low vision. For ex-
ample brown or pink colored tinted glasses and bifocal lens were 
used for albinism. But the kind of prescribed LVAs are mostly 
dependent upon visual function of each patient, not the causes 
of low vision. So each visual function should be considered first 
when prescribing the LVAs.
  In most patients, both near and distance BCVA were much 
improved when using the LVAs. This suggests that LVAs are ef-
fective in the improvement of visual function.
  In summary, although young patients still represent the ma-
jority of patients visiting the low vision clinics, we found that the 
number of elderly low vision patients is increasing and macular 
degeneration is becoming a leading cause of low vision. Rehabil-
itation using LVAs has improved the visual function of low vi-
sion patients. However, rehabilitation with LVAs is not yet suffi-
cient in low vision patients. Even if this study does not fully rep-
resent the characteristics of all low vision patients in Korea, it is 
the first survey for a large number of low vision patients over 
ten years in Korea. We believe that more active care and reha-
bilitation of low vision patients, especially elderly patients, are 
important and need in Korea and that this study will help in the 
planning of low vision services in Korea. 
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